Literature DB >> 11453738

Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.

R J Turesky1, V Parisod, T Huynh-Ba, S Langouët, F P Guengerich.   

Abstract

The metabolism of the mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) was investigated with human and rat liver microsomes, recombinant human cytochrome P450 1A2 (P450 1A2) expressed in Escherichia coli cells, and rat P450 1A2. Human liver microsomes and human P450 1A2 catalyzed the oxidation of the exocyclic amine group of MeIQx to form the genotoxic product 2-(hydroxyamino)-3,8-dimethylimidazo[4,5-f]quinoxaline (HONH-MeIQx). Human P450 1A2 also catalyzed the oxidation of C(8)-methyl group of MeIQx to form 2-amino-(8-hydroxymethyl)-3-methylimidazo[4,5-f]quinoxaline (8-CH(2)OH-IQx), 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carbaldehyde (IQx-8-CHO), and 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid (IQx-8-COOH). Thus, chemically stable C(8)-oxidation products of MeIQx may be useful biomarkers of P450 1A2 activity in humans. Rat liver microsomes were 10-15-fold less active than the human counterpart at both N-oxidation and C(8)-oxidation of MeIQx when expressed as nanomoles of product formed per minute per nanomoles of P450 1A2. Differences in regioselective oxidation of MeIQx were also observed with human and rat liver microsomes and the respective P450 1A2 orthologs. In contrast to human liver microsomes and P450 1A2, rat liver microsomes and purified rat P4501A2 were unable to catalyze the oxidation of MeIQx to the carboxylic derivative IQx-8-COOH, an important detoxication product formed in humans. However, rat liver microsomes and rat P4501A2, but not human liver microsomes or human P450 1A2, extensively catalyzed ring oxidation at the C-5 position of MeIQx to form the detoxication product 2-amino-3,8-dimethyl-5-hydroxyimidazo[4,5-f]quinoxaline (5-HO-MeIQx). There are important differences between human and rat P450 1A2, both in catalytic activities and oxidation pathways of MeIQx, that may affect the biological activity of this carcinogen and must be considered when assessing human health risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453738     DOI: 10.1021/tx010035s

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  11 in total

1.  Ultraperformance liquid chromatography-tandem mass spectrometry method for biomonitoring cooked meat carcinogens and their metabolites in human urine.

Authors:  Dan Gu; Melissa M Raymundo; Fred F Kadlubar; Robert J Turesky
Journal:  Anal Chem       Date:  2010-12-31       Impact factor: 6.986

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

3.  Mass spectrometric characterization of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine N-oxidized metabolites bound at Cys34 of human serum albumin.

Authors:  Lijuan Peng; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2011-10-04       Impact factor: 3.739

4.  Cytochrome P450-mediated metabolism and DNA binding of 2-amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice.

Authors:  Robert J Turesky; Erin E Bessette; Deborah Dunbar; Rosa G Liberman; Paul L Skipper
Journal:  Chem Res Toxicol       Date:  2011-12-28       Impact factor: 3.739

Review 5.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

6.  DNA adduct formation of 4-aminobiphenyl and heterocyclic aromatic amines in human hepatocytes.

Authors:  Gwendoline Nauwelaers; Erin E Bessette; Dan Gu; Yijin Tang; Julie Rageul; Valérie Fessard; Jian-Min Yuan; Mimi C Yu; Sophie Langouët; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2011-04-19       Impact factor: 3.739

7.  A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.

Authors:  Dan Gu; Lynn McNaughton; David Lemaster; Brian G Lake; Nigel J Gooderham; Fred F Kadlubar; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2010-04-19       Impact factor: 3.739

8.  Caffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans.

Authors:  Robert J Turesky; Kami K White; Lynne R Wilkens; Loïc Le Marchand
Journal:  Chem Res Toxicol       Date:  2015-08-06       Impact factor: 3.739

9.  Biomonitoring of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its carcinogenic metabolites in urine.

Authors:  Jean-Marie Fede; Anup P Thakur; Nigel J Gooderham; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

Review 10.  Dietary Carcinogens and DNA Adducts in Prostate Cancer.

Authors:  Medjda Bellamri; Robert J Turesky
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.